Determining pathways to improvements in fatigue in rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register for rheumatoid arthritis

Arthritis and Rheumatology

Volumn 67, Issue 9, 2015, Pages 2303-2310

  Druce, Katie L ^a   Jones, Gareth T ^a   MacFarlane, Gary J ^a   Basu, Neil ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; DAS28; DEPRESSION; DISABILITY SEVERITY; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL HEALTH; MIDDLE AGED; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT FORM 36; ARTHRITIS, RHEUMATOID; IMMUNOLOGY; PATHOPHYSIOLOGY; REGISTER; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; THEORETICAL MODEL; TREATMENT OUTCOME; UNITED KINGDOM;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; DEPRESSION; FATIGUE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; REGISTRIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 84940122100     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39238     Document Type: Article

References (49)

1. Suurmeijer TP, Waltz M, Moum T, Guillemin F, van Sonderen FL, Briancon S, et al., Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum 2001; 45: 111-21.
2. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA., Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum 2004; 51: 578-85.
3. Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, et al., Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 2005; 53: 697-702.
4. Mancuso CA, Paget SA, Charlson ME., Adaptations made by rheumatoid arthritis patients to continue working: a pilot study of workplace challenges and successful adaptations. Arthritis Care Res 2000; 13: 89-99.
5. Repping-Wuts H, Uitterhoeve R, van Riel P, van Achterberg T., Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 2008; 45: 995-1002.
6. Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, et al., Rheumatology outcomes: the patient's perspective. J Rheumatol 2003; 30: 880-3.
7. Hewlett S, Carr M, Ryan S, Kirwan J, Richards P, Carr A, et al., Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care 2005; 3: 131-42.
8. Hewlett S, Chalder T, Choy E, Cramp F, Davis B, Dures E, et al., Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology (Oxford) 2011; 50: 1004-6.
9. Aaronson LS, Teel CS, Cassmeyer V, Neuberger GB, Pallikkathayil L, Pierce J, et al., Defining and measuring fatigue. Image J Nurs Sch 1999; 31: 45-50.
10. Mancuso CA, Rincon M, Sayles W, Paget SA., Psychosocial variables and fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. J Rheumatol 2006; 33: 1496-502.
11. Van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P., Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 2010; 49: 1294-302.
12. Bergman M, Shahouri S, Shaver T, Anderson J, Weidensaul D, Busch R, et al., Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia. J Rheumatol 2009; 36: 2788-94.
13. Riemsma RP, Rasker JJ, Taal E, Griep EN, Wouters JM, Wiegman O., Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support. Rheumatology (Oxford) 1998; 37: 1042-6.
14. Wolfe F, Hawley DJ, Wilson K., The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996; 23: 1407-17.
15. Nikolaus S, Bode C, Taal E, van de Laar MA., Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken) 2013; 65: 1128-46.
16. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL., Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 2006; 45: 885-9.
17. Stebbings S, Treharne GJ., Fatigue in rheumatic disease: an overview. Int J Clin Rheumatol 2010; 5: 487-502.
18. Fifield J, Tennen H, Reisine S, McQuillan J., Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1851-7.
19. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, et al., Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009; 11: R7.
20. Talamo J, Frater A, Gallivan S, Young A., Use of the Short Form 36 (SF36) for health status measurement in rheumatoid arthritis. Rheumatology (Oxford) 1997; 36: 463-9.
21. Druce KL, Jones GT, Macfarlane GJ, Basu N., Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (Oxford) 2015; 54: 964-71.
22. Watson K, Symmons D, Griffiths I, Silman A., The British Society for Rheumatology Biologics Register. Ann Rheum Dis 2005; 64 Suppl 4: iv42-3.
23. Watson K, Hyrich K., The role of the British Society for Rheumatology Biologics Register (BSRBR) and the NICE guidelines for anti-TNF therapy. Musculoskeletal Care 2003; 1: 58-64.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
25. Ware JE Jr, Sherbourne CD., The MOS 36-item Short-Form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
26. Fluss E, Bond CM, Jones GT, Macfarlane GJ., The re-evaluation of the measurement of pain in population-based epidemiological studies: the SHAMA study. Br J Pain 2014. E-pub ahead of print.
27. Hewlett S, Dures E, Almeida C., Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for Severity, Effect, and Coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis Care Res (Hoboken) 2011; 63 Suppl: S263-86.
28. Hewlett S, Hehir M, Kirwan JR., Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Rheum 2007; 57: 429-39.
29. Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A., Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the Short Form 36-item health survey (SF-36). Br J Rheumatol 1998; 37: 425-36.
30. Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG, et al., Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 1999; 42: 1339-46.
31. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL., Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
32. Mankinen H, Kautiainen H, Hannonen P, Sokka T., Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 2005; 64: 1410-3.
33. Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, et al., Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009; 68: 954-60.
34. Kirwan JR, Reeback JS., Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986; 25: 206-9.
35. Aouizerat BE, Dodd M, Lee K, West C, Paul SM, Cooper BA, et al., Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 2009; 11: 27-41.
36. Bruce B, Fries J., The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003; 1: 20.
37. Vercoulen JH, Swanink CM, Galama JM, Fennis JF, Jongen PJ, Hommes OR, et al., The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998; 45: 507-17.
38. Joreskog KG, Sorbom D., LISREL 8: Structural equation modeling with the SIMPLIS command language. Chicago: Scientific Software International; 1993.
39. Acock AC., Discovering structural equation modeling using Stata. College Station (TX): Stata Press; 2013.
40. Treharne GJ, Lyons AC, Hale ED, Goodchild CE, Booth DA, Kitas GD., Predictors of fatigue over 1 year among people with rheumatoid arthritis. Psychol Health Med 2008; 13: 494-504.
41. Van Dartel SA, Repping-Wuts JW, van Hoogmoed D, Bleijenberg G, van Riel PL, Fransen J., Association between fatigue and pain in rheumatoid arthritis: does pain precede fatigue or does fatigue precede pain? Arthritis Care Res (Hoboken) 2013; 65: 862-9.
42. Cramp F, Hewlett S, Almeida C, Kirwan JR, Choy EH, Chalder T, et al., Non-pharmacological interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev 2013: CD008322.
43. Pollard L, Choy EH, Scott DL., The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol 2005; 23 Suppl 39: S43-52.
44. Scott DL, Smith C, Kingsley G., What are the consequences of early rheumatoid arthritis for the individual? Best Pract Res Clin Rheumatol 2005; 19: 117-36.
45. McWilliams DF, Zhang W, Mansell JS, Kiely PD, Young A, Walsh DA., Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study. Arthritis Care Res (Hoboken) 2012; 64: 1505-13.
46. Walsh DA, McWilliams DF., Pain in rheumatoid arthritis. Curr Pain Headache Rep 2012; 16: 509-17.
47. Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Pizzorni C, et al., Anti-TNF and sex hormones. Ann N Y Acad Sci 2006; 1069: 391-400.
48. Kristensen LE, Kapetanovic MC, Gulfe A, Soderlin M, Saxne T, Geborek P., Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology (Oxford) 2008; 47: 495-9.
49. Thyberg I, Dahlstrom O, Thyberg M., Factors related to fatigue in women and men with early rheumatoid arthritis: the Swedish TIRA study. J Rehabil Med 2009; 41: 904-12.